Melflufen and dexamethasone vs pomalidomide and dexamethasone in relapsed refractory multiple myeloma

OncoAlert and ecancer - ESMO 2021 Day 5

Managing patients with EGFR exon 20 ins in NSCLC and EGFR TKI toxicity

Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal mucosal melanoma

KRYSTAL-1: Adagrasib as monotherapy or combined with cetuximab in patients with CRC harboring a KRASG12C mutation

Anti-cancer drug price regulation in India: Financial implications and annual savings to patients

Neoadjuvant chemotherapy with CapeOx alone vs standard chemoradiotherapy (CRT) with Capecitabine for patients with LARC

Giredestrant plus palbociclib vs anastrozole plus palbociclib for post-menopausal, HER2-negative, untreated early breast cancer

Novel therapies in multiple myeloma

Abiraterone acetate plus prednisolone added to ADT + docetaxel, gives 25% reduction in risk of death compared to ADT + docetaxel alone in prostate cancer

OncoAlert and ecancer - ESMO 2021 Day 3

FOLFOXIRI + bevacizumab + atezolizumab versus FOLFOXIRI + bevacizumab as first-line treatment of unresectable mCRC patients